Laverdia-CA1 (Verdinexor) Tablets, 2.5 mg, 10 mg, and 50 mg

US) Dechra Veterinary Products

Revision date : 2022-03-01

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS05 GHS07
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

65-95

EC/CAS

557-04-0

Name of the chemical

Aluminium, zinc, magnesium and calcium stearates

Concentration

0.2-2

EC/CAS

9003-39-8

Name of the chemical

polyvinylpyrrolidone

Concentration

2-6

General Information

Version

2022-1

Revision date

2022-03-01

Product name

Laverdia-CA1 (Verdinexor) Tablets, 2.5 mg, 10 mg, and 50 mg

Product name

Laverdia-CA1 (Verdinexor) Tablets, 2.5 mg, 10 mg, and 50 mg

Identification on the label/Trade name

Aviation regulated liquid, n.o.s. (contains sevoflurane)

Product Synonyms

(Z)-3-[3-(3,5-Bis-trifluoromethylphenyl)-1H-[1,2,4]-triazol-1- yl]acrylic acid N"-pyridin-2-yl hydrazide; KY9; KPT-335; ALI-335; (Z)-3-[3-(3,5-Bis-trifluoromethylphenyl)-1H-[1,2,4]-triazol-1- yl]acrylic acid N"-pyridin-2-yl hydrazide; KY9; KPT-335; ALI-335; Verdinexor Tablets for dogs

Chemical name

Not Applicable

1.2.1 Relevant identified uses

Indicated for the treatment of lymphoma in dogs This SDS is written to address potential worker health and safety issues associated with the handling of the mixture

Icons in SDS

GHS05 GHS07 M004 M008 M009 M010

Company Information

company name

US) Dechra Veterinary Products

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H315, H318, H335, H361d, H372, H402

Hazard statements

Code

Statements

H315

Causes skin irritation

H318

Causes serious eye damage.

H335

May cause respiratory irritation

H361d

Suspected of damaging the unborn child.

H372

Causes damage to organs through prolonged or repeated exposure

H402

Harmful to aquatic life

Section 2

SECTION 2: Hazards identification

1272/2008 Classification of the substance or mixture

Signal word

Danger

Hazard statements

H315 Causes skin irritation. H318 Causes serious eye damage. H335 May cause respiratory irritation. H402 Harmful to aquatic life. H361d Suspected of damaging the unborn child. H372 Causes damage to organs (thymus and testes) through prolonged or repeated exposure Hazard(s) not otherwise classified Not Applicable

Prevention

P201 Obtain special instructions before use. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P261 Avoid breathing dust/fumes. P273 Avoid release to the environment. P280 Wear protective gloves, protective clothing, eye protection and face protection. P264 Wash all exposed external body areas thoroughly after handling.

Response

P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER/doctor/physician/first aider. P308+P313 If exposed or concerned: Get medical advice/attention. P312 Call a POISON CENTER/doctor/physician/first aider/if you feel unwell. P302+P352 IF ON SKIN: Wash with plenty of water. P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P332+P313 If skin irritation occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse.

Storage

P405 Store locked up. P403+P233 Store in a well-ventilated place. Keep container tightly closed.

Disposal

P501 Dispose of contents/container to authorised hazardous or special waste collection point in accordance with any local regulation.

Other hazards

Verdinexor is a selective inhibitor of nuclear export CRM1/XPO1 protein. Key clinical effects include headache, dizziness, lethargy, nausea, diarrhea, and sperm abnormalities. CRM1/XPO1 protein has shown to be involved during normal embryonic development. As such, based on the mechanism of action, a potential for verdinexor to adversely affect embryonic development cannot be ruled out in the absence of definitive data. Note This mixture is classified as hazardous under GHS as implemented by Regulation EC No

2.1 Classification of the substance or mixture

Safety Data Sheet according to OSHA HazCom Standard (2012) requirements (L.GHS.USA) NFPA 704 diamond Note: The hazard category numbers found in GHS classification in section 2 of this SDSs are NOT to be used to fill in the NFPA 704 diamond. Blue = Health Red = Fire Yellow = Reactivity White = Special (Oxidizer or water reactive substances) Classification Skin corrosion/irritation category 2, serious eye damage/eye irritation category 1, specific target organ toxicity – single exposure (respiratory tract irritation) category 3, hazardous to the aquatic environment acute hazard category 3, suspected of damaging the unborn child Reproductive toxicity Category 2

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.